The region of fibronectin encompassing type III repeats 4 -6 contains a low affinity heparin binding domain, but its physiological significance is not clear. We have studied whether this domain is able to interact Fibronectin (Fn) 1 is an extracellular matrix and plasma protein composed of structural domains that contain binding sites for other macromolecules (fibrin, heparin/proteoglycans, collagen), as well as for cells (reviewed in Hynes (1)). The NH 2 -terminal heparin binding domain or Hep I (see Fig. 1) also interacts with cell surfaces by binding to uncharacterized molecules and is mainly involved in formation of Fn matrices (1, 2). The Hep II domain displays the highest avidity for heparin and contains specific sequences which bind proteoglycans and/or the ␣41 integrin at the cell surface and induce cell adhesion (3-5). One of these sites is H1, which is a ligand for ␣41 in melanoma (6) and lymphoid cells (7). Two other sequences, CS-1 and CS-5, located within the IIICS segment (outside the Hep II domain) are also ligands for ␣41 (8 -11) and bind with different affinities (12). These previous studies have established that ␣41 may bind several sequences in the COOHterminal region of Fn and that these interactions are particularly important in lymphoid cells, where ␣41 is highly expressed.The central Hep III domain is less well studied because it binds heparin only at low salt concentration, and the physiological significance of this interaction is unclear. Using DNA affinity chromatography, we and others previously isolated proteolytic fragments from this region of Fn, which displayed low affinity binding to heparin. These include a 14-kDa fragment corresponding to FN-III1 repeat (13) and two fragments of 18 -20 kDa (FN-III4-1/2 5 repeats) (14) and 30 kDa (FN-III4 -6 repeats) (15) from human and bovine plasma Fn, respectively. We also previously reported that an 80-kDa tryptic fragment (FN-III4-1/2 FN-III11) binds heparin with low avidity (16). It is not known whether this heparin binding domain also interacts with cells.The present study was undertaken to further characterize the properties of the Hep III domain of Fn. To this effect, we have prepared recombinant fragments encompassing type III homology repeats from this region and have studied their cell binding activities. We show that a fragment containing the FN-III5 repeat mediates adhesion of T and B lymphoid cells efficiently. Furthermore, we have identified a novel 6-amino acid-sequence as the active site in FN-III5, and we show that activated ␣41 and ␣47 integrins are receptors for this sequence and the FN-III5 fragment. These results therefore establish a novel function for the Hep III Fn domain.